Company / Interest Expense per Share
Syndax Pharmaceuticals Inc Interest Expense per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2023
5-year range
$0.00 / $0.06
FY2020-FY2023
Trend
-94.6%
vs FY2022
Sector context
#38 of 43
Health Care
What the data says
Syndax Pharmaceuticals Inc's interest expense per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2023). Improved from $0.05 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2023 with a 3-year CAGR of -67.2%.
Improved from $0.05 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -67.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 43This company $0.00 Sector average $18.61
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 94.6% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -94.6% |
| FY2022 | $0.06 | +15.9% |
| FY2021 | $0.05 | -43.3% |
| FY2020 | $0.09 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026